Tilray Narrows Q2 Loss to $56.7M on Strong Revenue Growth

Ticker: TLRY · Form: 10-Q · Filed: 2024-01-09T00:00:00.000Z

Sentiment: mixed

Topics: earnings, revenue-growth, net-loss, cannabis

TL;DR

**Tilray's Q2 shows revenue up, losses down, signaling a potential turnaround.**

AI Summary

Tilray Brands, Inc. reported a net loss of $56.7 million for the three months ended November 30, 2023, a significant improvement from the $61.6 million net loss in the same period last year. The company's total revenues for the quarter were $193.8 million, up from $144.1 million year-over-year, driven by strong growth in its cannabis and beverage alcohol segments. This matters to investors because while the company is still unprofitable, its revenue growth and reduced net loss suggest progress towards profitability, which could positively impact the stock's long-term value.

Why It Matters

Tilray's continued revenue growth and reduced net loss indicate improving operational efficiency and market penetration, which are crucial for its path to sustained profitability and shareholder value.

Risk Assessment

Risk Level: medium — While Tilray is improving its financial performance, it remains unprofitable, and the cannabis industry faces ongoing regulatory and competitive challenges.

Analyst Insight

An investor should monitor Tilray's next earnings report for continued progress in reducing net losses and sustaining revenue growth, as these are key indicators for long-term stock performance. The current report shows positive trends but the company is not yet profitable.

Key Numbers

$193.8M — Total Revenues (Represents a significant increase from $144.1 million in the prior year, indicating strong sales growth.)
$56.7M — Net Loss (A reduction from $61.6 million in the prior year, showing progress towards profitability.)
732,907,552 — Common Shares Outstanding (As of November 30, 2023, important for per-share calculations.)

Key Players & Entities

Tilray Brands, Inc. (company) — the company filing the 10-Q
$56.7 million (dollar_amount) — net loss for the three months ended November 30, 2023
$61.6 million (dollar_amount) — net loss for the three months ended November 30, 2022
$193.8 million (dollar_amount) — total revenues for the three months ended November 30, 2023
$144.1 million (dollar_amount) — total revenues for the three months ended November 30, 2022
November 30, 2023 (date) — end of the reporting period for the 10-Q

Forward-Looking Statements

Tilray will continue to reduce its net loss in the next fiscal quarter. (Tilray Brands, Inc.) — medium confidence, target: 2024-02-29
Tilray's revenue growth will be sustained in the cannabis and beverage alcohol segments. (Tilray Brands, Inc.) — medium confidence, target: 2024-05-31

FAQ

What was Tilray Brands, Inc.'s net loss for the three months ended November 30, 2023, and how does it compare to the prior year?

Tilray Brands, Inc. reported a net loss of $56.7 million for the three months ended November 30, 2023. This is an improvement compared to the net loss of $61.6 million for the three months ended November 30, 2022.

What were the total revenues for Tilray Brands, Inc. for the three months ended November 30, 2023?

The total revenues for Tilray Brands, Inc. for the three months ended November 30, 2023, were $193.8 million.

How many common shares were outstanding for Tilray Brands, Inc. as of November 30, 2023?

As of November 30, 2023, Tilray Brands, Inc. had 732,907,552 common shares outstanding.

What was the company's fiscal year end, as stated in the filing?

The company's fiscal year end is May 31.

When was Tilray, Inc. formerly known as Tilray, Inc. and when did its name change to Tilray Brands, Inc.?

The company was formerly known as Tilray, Inc. and its name changed to Tilray Brands, Inc. on February 13, 2018.

From the Filing

0001437749-24-001001.txt : 20240109 0001437749-24-001001.hdr.sgml : 20240109 20240109170059 ACCESSION NUMBER: 0001437749-24-001001 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 127 CONFORMED PERIOD OF REPORT: 20231130 FILED AS OF DATE: 20240109 DATE AS OF CHANGE: 20240109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray Brands, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 824310622 FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 24523964 BUSINESS ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: Tilray, Inc. DATE OF NAME CHANGE: 20180213 10-Q 1 tlry20231130_10q.htm FORM 10-Q tlry20231130_10q.htm 0001731348 Tilray Brands, Inc. false --05-31 Q2 2023 0.0001 0.0001 1,198,000,000 1,198,000,000 732,907,552 732,907,552 656,655,455 656,655,455 0.0001 0.0001 10,000,000 10,000,000 0 0 0 0 0 15 15 15 0 0 100 0 0 8 3.50 0 0 60 0 0 1,000 0 2 7,000 500 7,438 7,500 7,000 500 66,000 66,000 3 3 10 10 November 30, 2025 November 30, 2025 25,000 25,000 1.00 1.00 5 5 15 15 181 181 July 31, 2033 July 31, 2033 25,000 25,000 1.00 1.00 5 5 15 15 196 196 July 31, 2033 July 31, 2033 1,250 1,250 1.50 1.50 5 5 10 10 12 12 August 31, 2026 August 31, 2026 3,750 3,750 1.50 1.50 5 5 20 20 23 23 August 31, 2026 August 31, 2026 5,000 5,000 2.15 2.15 5 5 250 250 December 31, 2023 December 31, 2023 1,200 1,200 4.26 4.26 1 1 100 100 December 31, 2023 December 31, 2023 1,500 1,500 2.00 2.00 5 5 94 94 April 30, 2025 April 30, 2025 3,500 3,500 4.59 4.59 5 5 52 52 August 31, 2028 August 31, 2028 22,635 22,635 1.5 1.5 10 10 57 57 October 31, 2030 October 31, 2030 90,000 90,000 5 5 875 875 1,750 1,750 June 30, 2028 June 30, 2028 June 30, 2028 5.20 5.20 5.25 5.25 5.00 5.00 5.20 5.20 4.00 4.00 5.25 5.25 136,740 5.00 5.00 6,209,000 5.95 1 732,907,552 0 0 110,000 20,000 7,000 0 4 103,401 5,651 1,817 27,107 120,568 — — — 4,181 — — 151 1,951 10,584 7,831 — — — — 74,681 5,500 3,768 20,704 128,399 4 0 0 0 0 false false false false 0001731348 2023-06-01 2023-11-30 xbrli:shares 0001731348 2024-01-05 thunderdome:item iso4217:USD 0001731348 2023-11-30 0001731348 2023-05-31 iso4217:USD xbrli:shares 0001731348 2023-09-01 2023-11-30 0001731348 2022-09-01 2022-11-30 0001731348 2022-06-01 2022-11-30 0001731348 tlry:CommonStockAndPreferredStockMember 2022-05-31 0001731348 us-gaap:AdditionalPaidInCapitalMember 2022-05-31 0001731348 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-05-31 0001731348 us-gaap:RetainedEarningsMember 2022-05-31 0001731348 us-gaap:NoncontrollingInterestMember 2022-05-31 0001731348 2022-05-31 0001731348 tlry:CommonStockAndPreferredStockMember 2022-06-01 2022-08-31 0001731348 us-gaap:AdditionalPaidInCapitalMember 2022-06-01 2022-08-31 0001731348 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-01 2022-08-31 0001731348 us-gaap:RetainedEarningsMember 2022-06-01 2022-08-31 0001731348 us-gaap:NoncontrollingInterestMember 2022-06-01 2022-08-31 0001731348 2022-06-01 2022-08-31 0001731348 tlry:HTInvestmentsMALLCNoteMember tlry:CommonStockAndPreferredStockMember 2022-06-01 2022-08-31 0001731348 tlry:HTInvestmentsMALLCNoteMember us-gaap:AdditionalPaidInCapitalMember 2022-06-01 2022-08-31 0001731348 tlry:HTInvestmentsMALLCNoteMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-01 2022-08-31 0001731348 tlry:HTInvestmentsMALLCNoteMember us-gaap:RetainedEarningsMember 2022-06-01 2022-08-31 0001731348 tlry:HTInvestmentsMALLCNoteMember us-gaap:NoncontrollingInterestMember 2022-06-01 2022-08-31 0001731348 tlry:HTInvestmentsMALLCNoteMember 2022-06-01 2022-08-31 0001731348 tlry:CommonStockAn